This content is only available within our institutional offering.

09 Sep 2025
Zenakine underpins Croda's premium beauty offering

Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
Zenakine underpins Croda's premium beauty offering
SkinBioTherapeutics Plc (SBTX:LON) | 14.5 0 0.0% | Mkt Cap: 37.5m
- Published:
09 Sep 2025 -
Author:
Karl Keegan -
Pages:
3 -
Croda International Plc (“Croda”), a global leader in smart science for high-performance ingredients and solutions, has expanded its premium beauty actives portfolio with the launch of Zenakine, a biotech-based neuroactive ingredient designed to counteract the effects of stress on the skin. Zenakine strengthens Croda’s position as a leader in differentiated, high-value actives, directly supporting its strategy to target fast-growing sectors within the beauty and personal care industry.